A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces ...

Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

A growing number of Americans are trying popular weight-loss drugs touted by celebrities, health care providers and others.

Mesoblast shares lifted in morning trade after the biotech said it had aligned with the US Food and Drug Administration (FDA) ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...

A top heart doctor has revealed the insidious supplements in medicine capsules that could increase your risk of a heart ...

Heart attack survival odds have dramatically improved over the past 5 decades, but more people are dying from chronic cardiac ...

Following a heart transplant, patients must undergo surgical biopsies so that clinicians can monitor for signs of organ rejection. A new study shows the promise of a biomarker that could allow doctors ...

Heart attacks are no longer the leading cause of heart disease-related death, but deaths from heart disease have still been responsible for more U.S. fatalities than any other cause, a new American ...